Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating a New Treatment Regimen for Patients With Multidrug-resistant TB (MDR-TB) - a Prospective Open-label Randomised Controlled Trial

NCT02454205 is registered in ClinicalTrials.gov with University of Cape Town as lead sponsor.

NCT NCT02454205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02454205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating a New Treatment Regimen for Patients With Multidrug-resistant TB (MDR-TB) - a Prospective Open-label Randomised Controlled Trial
Lead sponsor
University of Cape Town
Phase
Phase 2/3
Overall status
Completed
Start date
November 12, 2015
Completion date
August 30, 2021
Enrollment
154 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extensively-drug resistant tuberculosis, multidrug resistant tuberculosis, tuberculosis